Indeed, partial depletion of HSP90 in CLL cells resulted in reduced expression of CD79a, BCAP and PLCγ2 with significant inhibition of phosphorylation on ERK1/2 but not the total ERK1/2 protein levels (Figure 2D). This evidence concerns the gene MAPK3 and B-cell chronic lymphocytic leukemia.